Anika Therapeutics, Inc. Foreign Currency Transaction Gain (Loss), before Tax
Anika Therapeutics, Inc. (ANIK) reported Foreign Currency Transaction Gain (Loss), before Tax of -$400.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-03-03
- Anika Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2019-12-31 was -$300.00K.
- Anika Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$400.00K.
- Anika Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$200.00K.
- Anika Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$100.00K.
- Anika Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$500.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -$400.00K 10-K · filed 2026-03-03 | ||
| 2024-12-31 | -$200.00K 10-K · filed 2026-03-03 | ||
| 2023-12-31 | -$100.00K 10-K · filed 2026-03-03 | $100.00K 10-K · filed 2024-03-15 | |
| 2022-12-31 | -$500.00K 10-K · filed 2025-03-17 | ||
| 2021-12-31 | -$400.00K 10-K · filed 2024-03-15 | ||
| 2020-12-31 | $300.00K 10-K · filed 2023-03-16 | ||
| 2019-12-31 | -$300.00K 10-K · filed 2020-03-06 | -$300.00K 10-K · filed 2022-03-11 | |
| 2018-12-31 | -$400.00K 10-K/A · filed 2021-04-26 | ||
| 2017-12-31 | $700.00K 10-K · filed 2020-03-06 | ||
| 2016-12-31 | -$300.00K 10-K · filed 2019-02-27 | ||
| 2015-12-31 | -$400.00K 10-K · filed 2018-02-27 | $400.00K 10-K · filed 2016-03-10 | |
| 2014-12-31 | -$600.00K 10-K · filed 2017-02-24 | -$554.24K 10-K · filed 2015-03-13 | |
| 2013-12-31 | $259.00K 10-K · filed 2016-03-10 | $259.27K 10-K · filed 2014-03-13 | |
| 2012-12-31 | $200.45K 10-K · filed 2015-03-13 | ||
| 2011-12-31 | -$623.09K 10-K · filed 2014-03-13 | ||
| 2010-12-31 | -$7.70K 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |